granted
on 22 Mar 2024
Last Applicant/ Owned by
1551 Eastlake Avenue E, Suite 200
Seattle
WA
98102
Serial Number
97442381 filed on 03rd Jun 2022
Registration Number
N/A
Correspondent Address
Hoang-chi Truong
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientiRead More
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical diagnostic and prognostic testing services; providing medical immunosequencing-based diagnostic and prognostic testing for cancer, autoimmune disease and infection; consulting services in the field of medical immunosequencing-based testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical analysis services relating to the diagnosis and treatment of persons
Providing information about medical research in the field medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; medical laboratory immunosequencing-based services for analysis of biological samples
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical assay kits comprised of diagnostic reagents and assays for medical use, namely, to detect cancer, autoimmune disease and infection; Diagnostic kits comprised of medical immunosequencing-based diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing assay kits comprised of diagnostic reagents and assays for medical use , namely, to detect cancer, autoimmune disease and infection; Medical immunosequencing-based assay kits comprised of medical grade reagents and sample plates for detecting cancer, autoimmune disease and infection
No 97442381
No Service Mark
No 10214-2-039
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 22nd Mar 2024 | SOU EXTENSION 1 FILED |
| 22nd Mar 2024 | SOU EXTENSION 1 GRANTED |
| 26th Sep 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 01st Aug 2023 | PUBLISHED FOR OPPOSITION |
| 01st Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 27th Jun 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 23rd Jun 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
